Skip to main content
Erschienen in: Pediatric Radiology 2/2012

01.02.2012 | Original Article

Magnetic resonance diffusion tensor imaging (MRDTI) of the optic nerve and optic radiations at 3T in children with neurofibromatosis type I (NF-1)

verfasst von: Christopher G. Filippi, Aaron Bos, Joshua P. Nickerson, Michael B. Salmela, Chris J. Koski, Keith A. Cauley

Erschienen in: Pediatric Radiology | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Optic pathway glioma (OPG) is a characteristic hallmark of neurofibromatosis type I (NF-I).

Objective

To evaluate the feasibility of magnetic resonance diffusion tensor imaging (MRDTI) at 3T to detect abnormalities of the optic nerves and optic radiations in children with NF-I.

Materials and methods

3-T MRDTI was prospectively performed in 9 children with NF-I (7 boys, 2 girls, average age 7.8 years, range 3–17 years) and 44 controls (25 boys, 19 girls, average age 8.1 years, range 3–17 years). Fractional anisotropy (FA) and mean diffusivity were determined by region-of-interest analysis for the optic nerves and radiations. Statistical analysis compared controls to NF-I patients.

Results

Two NF-I patients had bilateral optic nerve gliomas, three had chiasmatic gliomas and four had unidentified neurofibromatosis objects (UNOs) along the optic nerve pathways. All NF-I patients had statistically significant decreases in FA and elevations in mean diffusivity in the optic nerves and radiations compared to age-matched controls.

Conclusion

MRDTI can evaluate the optic pathways in children with NF-I. Statistically significant abnormalities were detected in the diffusion tensor metrics of the optic nerves and radiations in children with NF-I compared to age-matched controls.
Literatur
1.
Zurück zum Zitat Stern J, Jakobiec FA, Housepian EM (1980) The architecture of optic nerve gliomas with and without neurofibromatosis. Arch Ophthalmol 98:505–511PubMedCrossRef Stern J, Jakobiec FA, Housepian EM (1980) The architecture of optic nerve gliomas with and without neurofibromatosis. Arch Ophthalmol 98:505–511PubMedCrossRef
2.
Zurück zum Zitat Lewis RA, Gerson LP, Axelson KA et al (1984) Neurofibromatosis. II. Incidence of optic nerve gliomata. Ophthalmology 91:929–935PubMed Lewis RA, Gerson LP, Axelson KA et al (1984) Neurofibromatosis. II. Incidence of optic nerve gliomata. Ophthalmology 91:929–935PubMed
3.
Zurück zum Zitat Gayre GS, Scott IU, Feuer W et al (2001) Long-term visual outcome in patients with anterior visual pathway gliomas. J Neuroophthalmol 21:1–7PubMedCrossRef Gayre GS, Scott IU, Feuer W et al (2001) Long-term visual outcome in patients with anterior visual pathway gliomas. J Neuroophthalmol 21:1–7PubMedCrossRef
4.
Zurück zum Zitat Rush JA, Younge BR, Campbell RJ et al (1982) Optic glioma: long-term follow-up of 85 histopathologically verified cases. Ophthalmology 89(11):1213–1219PubMed Rush JA, Younge BR, Campbell RJ et al (1982) Optic glioma: long-term follow-up of 85 histopathologically verified cases. Ophthalmology 89(11):1213–1219PubMed
5.
Zurück zum Zitat Lund AM, Skovby F (1991) Optic gliomas in children with neurofibromatosis type I. Eur J Pediatr 150:835–838PubMedCrossRef Lund AM, Skovby F (1991) Optic gliomas in children with neurofibromatosis type I. Eur J Pediatr 150:835–838PubMedCrossRef
6.
Zurück zum Zitat Thiagalingam S, Flaherty M, Billson F et al (2004) Neurofibromatosis type I and optic pathway gliomas: follow-up of 54 patients. Ophthalmology 111:568–577PubMedCrossRef Thiagalingam S, Flaherty M, Billson F et al (2004) Neurofibromatosis type I and optic pathway gliomas: follow-up of 54 patients. Ophthalmology 111:568–577PubMedCrossRef
7.
Zurück zum Zitat Listernick R, Charrow J, Greenwald M et al (1994) Natural history of optic pathway tumors in children with neurofibromatosis type I: a longitudinal study. J Pediatr 125:63–66PubMedCrossRef Listernick R, Charrow J, Greenwald M et al (1994) Natural history of optic pathway tumors in children with neurofibromatosis type I: a longitudinal study. J Pediatr 125:63–66PubMedCrossRef
8.
Zurück zum Zitat Hoyt WF, Baghdassarian SA (1969) Optic glioma of childhood: natural history and rationale for conservative management. Br J Ophthalmol 53:793–798PubMedCrossRef Hoyt WF, Baghdassarian SA (1969) Optic glioma of childhood: natural history and rationale for conservative management. Br J Ophthalmol 53:793–798PubMedCrossRef
9.
Zurück zum Zitat Listernick R, Darling C, Greenwald M et al (1995) Optic pathway tumors in children: the effect of neurofibromatosis type I on clinical manifestations and natural history. J Pediatr 127:718–722PubMedCrossRef Listernick R, Darling C, Greenwald M et al (1995) Optic pathway tumors in children: the effect of neurofibromatosis type I on clinical manifestations and natural history. J Pediatr 127:718–722PubMedCrossRef
10.
Zurück zum Zitat Wright JE, McDonald WI, Call NB (1980) Management of optic nerve gliomas. Br J Ophthalmol 64:545–552PubMedCrossRef Wright JE, McDonald WI, Call NB (1980) Management of optic nerve gliomas. Br J Ophthalmol 64:545–552PubMedCrossRef
11.
Zurück zum Zitat Listernick R, Louis DN, Packer RJ et al (1997) Optic pathway gliomas in children with neurofibromatosis I: consensus statement from the NF-I Optic Nerve Pathway Glioma Task Force. Ann Neural 41:143–149CrossRef Listernick R, Louis DN, Packer RJ et al (1997) Optic pathway gliomas in children with neurofibromatosis I: consensus statement from the NF-I Optic Nerve Pathway Glioma Task Force. Ann Neural 41:143–149CrossRef
12.
Zurück zum Zitat Listernick R, Charrow J, Guttmann DH (1999) Intracranial gliomas in neurofibromatosis type I. Am J Med Genet 89(1):38–44PubMedCrossRef Listernick R, Charrow J, Guttmann DH (1999) Intracranial gliomas in neurofibromatosis type I. Am J Med Genet 89(1):38–44PubMedCrossRef
13.
Zurück zum Zitat Grill J, Lather V, Rodriguez D et al (2000) When do children with optic pathway tumors need treatment? An ontological perspective in 106 patients treated in a single centre. Eur J Pediatr 159:692–696PubMedCrossRef Grill J, Lather V, Rodriguez D et al (2000) When do children with optic pathway tumors need treatment? An ontological perspective in 106 patients treated in a single centre. Eur J Pediatr 159:692–696PubMedCrossRef
14.
Zurück zum Zitat Deliganis AV, Geyer JR, Berger MS (1996) Prognostic significance of type I neurofibromatosis (von Recklinghausen disease) in childhood optic glioma. Neurosurgery 38:1114–1118PubMed Deliganis AV, Geyer JR, Berger MS (1996) Prognostic significance of type I neurofibromatosis (von Recklinghausen disease) in childhood optic glioma. Neurosurgery 38:1114–1118PubMed
15.
Zurück zum Zitat Gottschalk S, Tavakolian R, Buske A et al (1999) Spontaneous remission of chiasmatic/hypothalamic masses in neurofibromatosis type I: a report of two cases. Neuroradiology 41:199–201PubMedCrossRef Gottschalk S, Tavakolian R, Buske A et al (1999) Spontaneous remission of chiasmatic/hypothalamic masses in neurofibromatosis type I: a report of two cases. Neuroradiology 41:199–201PubMedCrossRef
16.
Zurück zum Zitat Schmandt SM, Packer RJ, Vezina LG (2000) Spontaneous regression of low-grade astrocytomas in childhood. Pediatr Neurosurg 32:132–136PubMedCrossRef Schmandt SM, Packer RJ, Vezina LG (2000) Spontaneous regression of low-grade astrocytomas in childhood. Pediatr Neurosurg 32:132–136PubMedCrossRef
17.
Zurück zum Zitat Perilongo G, Moras P, Carollo C et al (1999) Spontaneous partial regression of a low-grade glioma in children with neurofibromatosis-I: a real possibility. J Child Neurol 14:352–356PubMedCrossRef Perilongo G, Moras P, Carollo C et al (1999) Spontaneous partial regression of a low-grade glioma in children with neurofibromatosis-I: a real possibility. J Child Neurol 14:352–356PubMedCrossRef
18.
Zurück zum Zitat Blazo MA, Lewis RA, Chintagumpala MM (2004) Outcomes of systematic screening for optic pathway tumors in children with neurofibromatosis type I. Am J Med Genet A 127A(3):224–229PubMedCrossRef Blazo MA, Lewis RA, Chintagumpala MM (2004) Outcomes of systematic screening for optic pathway tumors in children with neurofibromatosis type I. Am J Med Genet A 127A(3):224–229PubMedCrossRef
19.
Zurück zum Zitat Stern J, DiGiacinto GV, Housepian EM (1979) Neurofibromatosis and optic glioma: clinical and morphological correlations. Neurosurgery 4:524–528PubMedCrossRef Stern J, DiGiacinto GV, Housepian EM (1979) Neurofibromatosis and optic glioma: clinical and morphological correlations. Neurosurgery 4:524–528PubMedCrossRef
20.
Zurück zum Zitat Borit A, Richardson EP Jr (1982) The biological and clinical behavior of pilocytic astrocytomas of the optic pathways. Brain 105:161–187PubMedCrossRef Borit A, Richardson EP Jr (1982) The biological and clinical behavior of pilocytic astrocytomas of the optic pathways. Brain 105:161–187PubMedCrossRef
21.
Zurück zum Zitat Balcer LJ, Liu GT, Heller G et al (2001) Visual loss in children with neurofibromatosis type I and optic pathway gliomas: relation to tumor location by magnetic resonance imaging. Am J Ophthalmol 131(4):442–445PubMedCrossRef Balcer LJ, Liu GT, Heller G et al (2001) Visual loss in children with neurofibromatosis type I and optic pathway gliomas: relation to tumor location by magnetic resonance imaging. Am J Ophthalmol 131(4):442–445PubMedCrossRef
22.
Zurück zum Zitat van Engelen SJPM, Krab LC, Moll HA et al (2008) Quantitative differentiation between healthy and disordered brain matter in patients with neurofibromatosis type I using diffusion tensor imaging. AJNR 29:816–822PubMedCrossRef van Engelen SJPM, Krab LC, Moll HA et al (2008) Quantitative differentiation between healthy and disordered brain matter in patients with neurofibromatosis type I using diffusion tensor imaging. AJNR 29:816–822PubMedCrossRef
23.
Zurück zum Zitat Salmela MB, Cauley KA, Nickerson JP et al (2010) Magnetic resonance diffusion tensor imaging (MRDTI) and tractography in children with septo-optic dysplasia. Pediatr Radiol 40(5):708–713PubMedCrossRef Salmela MB, Cauley KA, Nickerson JP et al (2010) Magnetic resonance diffusion tensor imaging (MRDTI) and tractography in children with septo-optic dysplasia. Pediatr Radiol 40(5):708–713PubMedCrossRef
24.
Zurück zum Zitat Yamamoto A, Miki Y, Urayama S (2007) Diffusion tensor fiber tractography of the optic radiation: analysis with 6-, 12-, 40-, and 81-directional motion-probing gradients. A preliminary study. AJNR 28:92–96PubMed Yamamoto A, Miki Y, Urayama S (2007) Diffusion tensor fiber tractography of the optic radiation: analysis with 6-, 12-, 40-, and 81-directional motion-probing gradients. A preliminary study. AJNR 28:92–96PubMed
25.
Zurück zum Zitat Basser PJ, Jones DK (2002) Diffusion-tensor MRI: theory, experimental design, and data analysis-a technical review. NMR Biomed 15:457–467CrossRef Basser PJ, Jones DK (2002) Diffusion-tensor MRI: theory, experimental design, and data analysis-a technical review. NMR Biomed 15:457–467CrossRef
26.
Zurück zum Zitat Mori H, Abe O, Okubo T et al (2001) Diffusion property in a hamartomatous lesion of neurofibromatosis type I. J Comput Assist Tomogr 25:537–539PubMedCrossRef Mori H, Abe O, Okubo T et al (2001) Diffusion property in a hamartomatous lesion of neurofibromatosis type I. J Comput Assist Tomogr 25:537–539PubMedCrossRef
27.
Zurück zum Zitat Eastwood JD, Fiorella DJ, MacFall JF et al (2001) Increased brain apparent diffusion coefficient in children with neurofibromatosis type I. Radiology 219:354–358PubMed Eastwood JD, Fiorella DJ, MacFall JF et al (2001) Increased brain apparent diffusion coefficient in children with neurofibromatosis type I. Radiology 219:354–358PubMed
28.
Zurück zum Zitat Alkan A, Sigirci A, Kutlu R et al (2005) Neurofibromatosis type I: diffusion weighted imaging findings of brain. Eur J Radiol 56:229–234PubMedCrossRef Alkan A, Sigirci A, Kutlu R et al (2005) Neurofibromatosis type I: diffusion weighted imaging findings of brain. Eur J Radiol 56:229–234PubMedCrossRef
29.
Zurück zum Zitat Tognini G, Ferrozzi F, Garlaschi G et al (2005) Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type I. J Comput Assist Tomogr 29:298–304PubMedCrossRef Tognini G, Ferrozzi F, Garlaschi G et al (2005) Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type I. J Comput Assist Tomogr 29:298–304PubMedCrossRef
30.
Zurück zum Zitat Zamboni SL, Loenneker T, Boltshauser E et al (2007) Contribution of diffusion tensor MR imaging in detecting cerebral microstructural changes in adults with neurofibromatosis type I. AJNR 28:773–776PubMed Zamboni SL, Loenneker T, Boltshauser E et al (2007) Contribution of diffusion tensor MR imaging in detecting cerebral microstructural changes in adults with neurofibromatosis type I. AJNR 28:773–776PubMed
31.
Zurück zum Zitat Nickerson JP, Salmela MB, Koski CJ et al (2010) Diffusion tensor imaging of the pediatric optic nerve: intrinsic and extrinsic pathology compared to normal controls. J Magn Reson Imaging 32:76–81PubMedCrossRef Nickerson JP, Salmela MB, Koski CJ et al (2010) Diffusion tensor imaging of the pediatric optic nerve: intrinsic and extrinsic pathology compared to normal controls. J Magn Reson Imaging 32:76–81PubMedCrossRef
32.
Zurück zum Zitat Sener RN (2002) Diffusion MR in neurofibromatosis type I: ADC evaluations of the optic pathways and a comparison with normal individuals. Comput Med Imaging Graph 26(2):59–64PubMedCrossRef Sener RN (2002) Diffusion MR in neurofibromatosis type I: ADC evaluations of the optic pathways and a comparison with normal individuals. Comput Med Imaging Graph 26(2):59–64PubMedCrossRef
33.
Zurück zum Zitat Ono J, Harada K, Mano T et al (1997) Differentiation of dys- and demyelination using diffusional anisotropy. Pediatr Radiol 16:63–66 Ono J, Harada K, Mano T et al (1997) Differentiation of dys- and demyelination using diffusional anisotropy. Pediatr Radiol 16:63–66
34.
Zurück zum Zitat DiPaolo DP, Zimmerman RA, Rorke LB et al (1995) Neurofibromatosis type I: pathologic substrate of high signal intensity foci in the brain. Radiology 195:721–724PubMed DiPaolo DP, Zimmerman RA, Rorke LB et al (1995) Neurofibromatosis type I: pathologic substrate of high signal intensity foci in the brain. Radiology 195:721–724PubMed
35.
Zurück zum Zitat Trip SA, Wheeler-Kingshott C, Jones SJ et al (2006) Optic nerve diffusion tensor imaging in optic neuritis. Neuorimage 30:498–505CrossRef Trip SA, Wheeler-Kingshott C, Jones SJ et al (2006) Optic nerve diffusion tensor imaging in optic neuritis. Neuorimage 30:498–505CrossRef
36.
Zurück zum Zitat Xu J, Sun SW, Naismith RT et al (2008) Assessing optic nerve pathology with diffusion MRI: from mouse to human. NMR Biomed 21:928–940PubMedCrossRef Xu J, Sun SW, Naismith RT et al (2008) Assessing optic nerve pathology with diffusion MRI: from mouse to human. NMR Biomed 21:928–940PubMedCrossRef
Metadaten
Titel
Magnetic resonance diffusion tensor imaging (MRDTI) of the optic nerve and optic radiations at 3T in children with neurofibromatosis type I (NF-1)
verfasst von
Christopher G. Filippi
Aaron Bos
Joshua P. Nickerson
Michael B. Salmela
Chris J. Koski
Keith A. Cauley
Publikationsdatum
01.02.2012
Verlag
Springer-Verlag
Erschienen in
Pediatric Radiology / Ausgabe 2/2012
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-011-2216-y

Weitere Artikel der Ausgabe 2/2012

Pediatric Radiology 2/2012 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.